SATB2 dysregulation has also been implicated in the development of PCM and small intestinal metaplasia, suggesting that PCM may represent a precancerous metaplastic phenotype in UC [13, 14, 15]. The gene discussed is SATB2; the disease is paracoccidioidomycosis.